融捷健康(300247) - 2025 Q3 - 季度财报

Revenue and Profit - Revenue for Q3 2025 reached ¥219,131,373.02, an increase of 53.87% year-over-year, and cumulative revenue for the year-to-date is ¥651,895,498.63, up 37.01%[5] - Net profit attributable to shareholders for Q3 2025 was ¥19,006,715.87, a significant increase of 144.92% compared to the same period last year, with year-to-date net profit at ¥66,530,456.08, up 82.59%[5] - Total operating revenue for the current period reached ¥651,895,498.63, a 37% increase from ¥475,799,143.25 in the previous period[30] - Net profit for the current period was ¥91,494,163.14, representing an 82.3% increase compared to ¥50,135,304.15 in the previous period[31] - The net profit attributable to shareholders of the parent company was ¥66,530,456.08, up 82.7% from ¥36,436,656.27[31] Earnings Per Share - The basic and diluted earnings per share for Q3 2025 were both ¥0.0236, reflecting a 143.30% increase year-over-year, with year-to-date earnings per share at ¥0.0827, up 82.56%[5] - Basic and diluted earnings per share increased to ¥0.0827 from ¥0.0453, reflecting a 82.7% growth[32] Assets and Liabilities - Total assets at the end of Q3 2025 amounted to ¥1,483,623,693.28, representing a 13.85% increase from the end of the previous year[5] - Total assets increased to ¥1,483,623,693.28 from ¥1,303,178,909.04, marking a growth of about 13.83%[27] - Total current assets reached ¥1,037,094,250.29, up from ¥947,370,678.98, representing an increase of approximately 9.46%[27] - The total non-current assets amounted to ¥446,529,442.99, up from ¥355,808,230.06, reflecting an increase of approximately 25.5%[27] - Total liabilities increased to ¥254,085,300.91 from ¥161,355,071.96, indicating a 57.3% rise[28] - The total liabilities include accounts payable of ¥62,784,606.03, which increased from ¥58,698,257.52, showing a rise of about 10.5%[27] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥42,264,663.01, a substantial increase of 172.92%[5] - The company reported a significant increase in cash inflow from operating activities, up ¥169,880,100, or 35.16% year-over-year[21] - Cash inflows from operating activities totaled ¥652,982,438.87, a significant rise from ¥483,102,291.60 in the previous period[33] - The net cash flow from operating activities was $42,264,663.01, an increase from $15,485,973.51 in the previous period, reflecting a significant improvement[34] - Cash inflow from investment activities totaled $587,218,940.13, compared to $510,618,352.37 in the prior period, indicating a growth of approximately 15%[34] Shareholder Information - Total number of common shareholders at the end of the reporting period is 29,269[23] - The largest shareholder, Rongjie Investment Holdings, holds 14.54% of shares, totaling 116,912,302 shares[23] Other Financial Metrics - The company has seen a 100% increase in lease liabilities due to new warehouse leases during the reporting period[17] - The company reported a decrease in employee compensation payable from ¥30,260,509.28 to ¥29,310,627.78, a decline of approximately 3.1%[27] - The company reported a decrease in other comprehensive income, with a net amount of -¥3,779,607.86 compared to -¥3,571,132.45 in the previous period[32] - Cash outflow from financing activities was $8,609,201.54, down from $9,826,483.54, representing a decrease of about 12.4%[34] - The net increase in cash and cash equivalents was $7,272,153.87, a significant drop from $88,453,916.30 in the previous period[34] Accounting Standards - The company will implement new accounting standards starting in 2025, but this does not apply to the current reporting period[35] - The company did not undergo an audit for the third quarter financial report[36]